CIK 0001680581
- Non-accelerated filer
- Smaller reporting company
Fulcrum Therapeutics, Inc.
Sign in to watch- Ticker
- FULC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474839948
- Phone
- +1 617-651-8851
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-29 | Gould Robert J | Sale | −1,390 | $20.08 | $28K | 549,036 |
| 2020-05-28 | Cadavid Diego SVP Clinical Development | Exercise or conversion | +600 | $4.83 | $3K | 67,385 |
| 2020-05-28 | Cadavid Diego SVP Clinical Development | Sale | −600 | $20.00 | $12K | 66,785 |
| 2020-05-28 | Cadavid Diego SVP Clinical Development | Exercise or conversion · Stock Option (right to buy) | −600 | 15,397 | ||
| 2020-05-28 | Gould Robert J | Sale | −1,919 | $20.01 | $38K | 550,426 |
| 2020-05-28 | Wallace Owen B. Chief Scientific Officer | Exercise or conversion | +2,232 | $7.84 | $17K | 129,320 |
| 2020-05-28 | Wallace Owen B. Chief Scientific Officer | Sale | −2,232 | $20.00 | $45K | 127,088 |
| 2020-05-28 | Wallace Owen B. Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −2,232 | 85,034 | ||
| 2020-05-27 | Wallace Owen B. Chief Scientific Officer | Exercise or conversion | +448 | $7.84 | $4K | 127,536 |
| 2020-05-27 | Wallace Owen B. Chief Scientific Officer | Sale | −448 | $20.00 | $9K | 127,088 |
| 2020-05-27 | Wallace Owen B. Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −448 | 87,266 | ||
| 2020-05-26 | Wallace Owen B. Chief Scientific Officer | Exercise or conversion | +412 | $7.84 | $3K | 127,500 |
| 2020-05-26 | Wallace Owen B. Chief Scientific Officer | Sale | −412 | $20.00 | $8K | 127,088 |
| 2020-05-26 | Wallace Owen B. Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −412 | 87,714 | ||
| 2020-05-26 | Gould Robert J | Sale | −2,500 | $20.00 | $50K | 552,345 |
| 2020-05-12 | Cadavid Diego SVP Clinical Development | Exercise or conversion | +1,860 | $4.83 | $9K | 68,645 |
| 2020-05-12 | Cadavid Diego SVP Clinical Development | Sale | −1,860 | $18.00 | $33K | 66,785 |
| 2020-05-12 | Cadavid Diego SVP Clinical Development | Exercise or conversion · Stock Option (right to buy) | −1,860 | 15,997 | ||
| 2020-05-11 | Thomson Peter G. VP Finance & Accounting | Sale | −7,500 | $16.00 | $120K | 21,071 |
| 2020-03-02 | Cadavid Diego SVP Clinical Development | Sale | −1,828 | $17.26 | $32K | 67,100 |
Page 12 of 15 · 291 trades